MCID: ESN007
MIFTS: 61

Eosinophilia malady

Categories: Genetic diseases, Immune diseases, Blood diseases, Rare diseases

Aliases & Classifications for Eosinophilia

About this section

Aliases & Descriptions for Eosinophilia:

Name: Eosinophilia 11 26 49 38 13 67
Eosinophilic Leukocytosis 11
 
Eosinophil Count Raised 11
Eosinophilic Disorder 67

Classifications:



External Ids:

Disease Ontology11 DOID:999
ICD1029 D72.1
ICD9CM31 288.3
MeSH38 D004802

Summaries for Eosinophilia

About this section
Wikipedia:70 Eosinophilia is a condition in which the eosinophil count in the peripheral blood exceeds 4.5×108/L... more...

MalaCards based summary: Eosinophilia, also known as eosinophilic leukocytosis, is related to keratoconjunctivitis and loeffler syndrome, and has symptoms including abdominal pain, chest pain and constipation. An important gene associated with Eosinophilia is PDGFRB (Platelet Derived Growth Factor Receptor Beta), and among its related pathways are Osteoblast Signaling and Vemurafenib Pathway, Pharmacodynamics. Affiliated tissues include myeloid, lung and bone, and related mouse phenotypes are digestive/alimentary and respiratory system.

Related Diseases for Eosinophilia

About this section

Diseases in the Eosinophilia family:

Eosinophilia, Familial

Diseases related to Eosinophilia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 482)
idRelated DiseaseScoreTop Affiliating Genes
1keratoconjunctivitis29.8IL4, IL5, RNASE3
2loeffler syndrome29.6CCL11, CSF2, EPX, FIP1L1, IL13, IL2
3churg-strauss syndrome29.6IL13, IL4, IL5, RNASE3
4skin disease29.6IL13, IL5, RNASE3
5myelodysplastic syndrome29.6ACSL6, CSF2, ETV6, IL3, PDGFRB
6acute myocardial infarction29.0CSF2, ETV6, IL2
7atopy28.4CCL11, EPX, IL13, IL4, IL5, RNASE3
8malaria27.6CCL11, CCL5, CSF2, IL13, IL2, IL4
9asthma26.1CCL11, CCL24, CCL26, CCL5, CCR3, CSF2
10eosinophilia-myalgia syndrome12.2
11myeloproliferative disorder with eosinophilia12.2
12pulmonary eosinophilia12.1
13episodic angioedema with eosinophilia12.1
14eosinophilia, familial12.0
15myeloid and lymphoid neoplasms with eosinophilia and abnormalities of pdgfra, pdgfrb, and fgfr111.9
16proton-pump inhibitor-responsive esophageal eosinophilia11.9
17drug rash with eosinophilia and systemic symptoms11.8
18sclerosing mucoepidermoid carcinoma with eosinophilia11.8
19neutropenia lethal congenital with eosinophilia11.7
20lymphoadenopathic mastocytosis with eosinophilia11.7
21myalgia-eosinophilia syndrome associated with tryptophan11.7
22eosinophilic pneumonia11.5
23omenn syndrome11.5
24chronic eosinophilic pneumonia11.4
25toxocariasis11.0
26eosinophilic fasciitis11.0
27idiopathic acute eosinophilic pneumonia11.0
28trichinosis11.0
29histiocytoid hemangioma11.0
30kimura disease11.0
31wells syndrome11.0
32fascioliasis11.0
33juvenile temporal arteritis11.0
34trichostrongylosis11.0
35aggressive systemic mastocytosis11.0
36pdgfrb-associated chronic eosinophilic leukemia10.9
37hyper-ige recurrent infection syndrome, autosomal recessive10.8
38hyper-ige recurrent infection syndrome10.8
39neutropenia, severe congenital 3, autosomal recessive10.7
40hemophagocytic lymphohistiocytosis, familial, 110.7
41ichthyosis prematurity syndrome10.7
42ichthyosis, congenital, autosomal recessive 110.7
43intestinal schistosomiasis10.7
44myeloid and lymphoid neoplasms associated with pdgfra rearrangement10.7
45myeloid neoplasms associated with pdgfrb rearrangement10.7
46myeloid and lymphoid neoplasms associated with fgfr1 abnormalities10.7
47paragonimiasis10.7
48clonorchiasis10.7
49cystic echinococcosis10.7
50keratinizing squamous cell carcinoma10.7

Comorbidity relations with Eosinophilia via Phenotypic Disease Network (PDN):


Hypertension, EssentialDeficiency Anemia
Ischemic Heart DiseaseHeart Disease
Acute CystitisBronchitis

Graphical network of the top 20 diseases related to Eosinophilia:



Diseases related to eosinophilia

Symptoms for Eosinophilia

About this section

UMLS symptoms related to Eosinophilia:


abdominal pain, chest pain, constipation, coughing, diarrhea, dyspepsia, heartburn, nausea and vomiting, snoring, gastrointestinal gas

Drugs & Therapeutics for Eosinophilia

About this section

Drugs for Eosinophilia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 291)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
BudesonideapprovedPhase 4, Phase 2, Phase 342251333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide MMX
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
Horacort
 
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
2
Omalizumabapproved, investigationalPhase 4, Phase 2, Phase 1143242138-07-4
Synonyms:
242138-07-4
D05251
Ig gamma-1 chain C region
Omalizumab
 
Omalizumab (USAN/INN)
Omalizumab (genetical recombination)
Omalizumab (genetical recombination) (JAN)
Xolair
Xolair (TN)
3
Nitric OxideapprovedPhase 4, Phase 259910102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
4
MontelukastapprovedPhase 4, Phase 3, Phase 1266158966-92-85281040
Synonyms:
(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
151767-02-1 (sodium)
158966-92-8
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
AC1NQXXW
Apxi toxin
BIDD:GT0394
Brondilat
Brondilat (TN)
C07482
C35H36ClNO3S
CHEBI:50730
CHEMBL787
CID5281040
 
D08229
DB00471
HMS2089D07
HSDB 7582
LS-173539
MK 0476
MK-0476
Montair
Montelukast
Montelukast (INN)
Montelukast [INN:BAN]
Montelukastum
Montélukast
Singulair
Singular
UNII-MHM278SD3E
montelukast
sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
5
Ciclesonideapproved, investigationalPhase 474126544-47-6, 141845-82-1444033
Synonyms:
(R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate
126544-47-6
141845-82-1
AC-1330
Alvesco
Alvesco (TN)
Alvesco HFA
B-9207-015
BTR-15
BTR-15K
BY-9010
BYK-20426
CID6918155
Ciclesonide
 
Ciclesonide (JAN/USAN/INN)
Ciclesonide [INN]
D01703
KS-1165
LS-186047
MolPort-005-940-705
NCGC00167972-01
Omnair
Omnaris
Omnaris HFA
Osonase
Osonide
RPR 251526
TBN-15
UNII-S59502J185
6
Methylprednisoloneapproved, vet_approvedPhase 4, Phase 3115383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
7
Histamine PhosphateapprovedPhase 4, Phase 3103351-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
 
EINECS 200-118-4
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
Histaminum
LS-78569
UNII-QWB37T4WZZ
8
Prednisoloneapproved, vet_approvedPhase 4, Phase 3115350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
9
Lansoprazoleapproved, investigationalPhase 4, Phase 2, Phase 1207103577-45-33883
Synonyms:
103577-45-3
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
A 65006
A-65006
AB00052388
ABT-006
AC1L1GX8
AG 1749
AG-1749
Abbot Brand of Lansoprazole
Agopton
Almirall Brand of Lansoprazole
Amarin
Aprazol
BIDD:GT0006
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
Bamalite
Bio-0824
Biuret
Biuret Gr
Biuret Reagent
Biuret Reagent Solution
Blason
C058687
C16H14F3N3O2S
CAS-103577-45-3
CG-4801
CHEBI:6375
CHEMBL480
CID3883
CPD000058469
Compraz
D00355
DB00448
Dakar
DivK1c_000920
EU-0100709
FT-0082011
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS502N22
HSDB 7204
Hoechst Brand of Lansoprazole
Hormona Brand of Lansoprazole
I06-0018
IDI1_000920
Ilsatec
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
L 8533
L8533_SIGMA
LS-33080
Lancid
Lanfast
Lanproton
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
Lansoprazole
Lansoprazole (JAN/USP/INN)
Lansoprazole [USAN:BAN:INN]
Lansoprazole [Usan:Ban:Inn]
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
Lanston
 
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle Brand of Lansoprazole
Limpidex
Linamarin
Lopac-L-8533
Lopac0_000709
MLS-0003247.0001
MLS000069705
MLS000759405
MLS001074170
Mesactol
MolPort-003-666-508
MolPort-006-394-760
Monolitum
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-06
NCGC00015615-11
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NINDS_000920
Ogast
Ogastro
Opiren
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
PrevOnco
Prevacid
Prevacid (TN)
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid SoluTab
Prevacid Solutab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
Prevpac
Prezal
Pro Ulco
Promeco
Promeco Brand of Lansoprazole
Promp
Prosogan
S1354_Selleck
SAM001246544
SMR000058469
SPBio_000488
SPBio_002992
SPECTRUM1503926
STK621169
Salvar Brand of Lansoprazole
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
Spectrum_001580
Suprecid
TAK 390MR
TAK-390MR
TAK390MR
TAP Brand of Lansoprazole
TL8000155
Takeda Brand of Lansoprazole
Takepron
Tecnobio Brand of Lansoprazole
UNII-0K5C5T2QPG
Ulpax
Vinas Brand of Lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton
lansoprazole
lansoprazole sulphone
lanzoprazole
10
HistamineapprovedPhase 4, Phase 3103475614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
11
VancomycinapprovedPhase 43221404-90-6441141, 14969
Synonyms:
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(2.2Sp,3.5sa,2.6sp)-O(4.2),C(3.4):c(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
1404-90-6
1404-93-9 (hydrochloride)
64685-75-2 (sulfate)
AC1L24VU
AC1L9AMI
AC1Q29OH
BIDD:GT0353
C06689
C66H75Cl2N9O24
CHEBI:28001
CHEMBL262777
CID14969
CID441141
CID5311496
CID6426898
CID6917992
D00212
DB00512
EINECS 215-772-6
HSDB 3262
LMPK14000004
 
LS-161387
Lopac0_001267
MolPort-001-794-649
NCGC00162383-02
Prestwick0_000497
Prestwick1_000497
Prestwick2_000497
SPBio_002314
UNII-6Q205EH1VU
VAN
VANCOMYCIN
Vancocin
Vancocin (TN)
Vancocin HCL
Vancomicina
Vancomicina [INN-Spanish]
Vancomycin
Vancomycin (USP)
Vancomycin HCL
Vancomycin [USAN:INN:BAN]
Vancomycine
Vancomycine [INN-French]
Vancomycinum
Vancomycinum [INN-Latin]
nchembio.350-comp1
12
MentholapprovedPhase 423532216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
13Dermatologic AgentsPhase 4, Phase 3, Phase 2, Phase 15674
14
FluticasonePhase 4, Phase 3, Phase 263090566-53-3, 80474-14-262924, 22833648
Synonyms:
90566-53-3
AC-456
AC1NSJZT
Asmatil
Axotide
BIDD:GT0819
Brethal
C07815
CHEMBL1201396
CID5311101
Cultivate
Cutivate
D07981
Flixonase
Flixonase Nasal Spray
Flixotide
Flixotide Disk
 
Flixotide Disks
Flixotide Inhaler
Flonase
Flovent
Flovent Diskus
Flovent Rotadisk
Fluinol
Flunase
Flusonal
Fluspiral
Fluticaps
Fluticaps (TN)
Fluticasone (INN)
Fluticasonpropionat Allen
Flutide
Flutivate
MolPort-006-666-449
S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate
fluticasone
15Anti-Asthmatic AgentsPhase 4, Phase 3, Phase 2, Phase 13369
16ImmunoglobulinsPhase 4, Phase 3, Phase 2, Phase 16045
17HormonesPhase 4, Phase 2, Phase 3, Phase 113979
18Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 2, Phase 3, Phase 112767
19Hormone AntagonistsPhase 4, Phase 2, Phase 3, Phase 112778
20glucocorticoidsPhase 4, Phase 2, Phase 3, Phase 14920
21Bronchodilator AgentsPhase 4, Phase 3, Phase 22856
22Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 2, Phase 110355
23Leukotriene AntagonistsPhase 4, Phase 3, Phase 1291
24AntibodiesPhase 4, Phase 3, Phase 2, Phase 16045
25Antibodies, MonoclonalPhase 4, Phase 3, Phase 2, Phase 13795
26Anti-Allergic AgentsPhase 4, Phase 3, Phase 2, Phase 11490
27Respiratory System AgentsPhase 4, Phase 3, Phase 2, Phase 14818
28Autonomic AgentsPhase 4, Phase 3, Phase 29774
29Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 122776
30Adrenergic beta-AgonistsPhase 4, Phase 21640
31Adrenergic beta-2 Receptor AgonistsPhase 4, Phase 2925
32Adrenergic AgonistsPhase 4, Phase 22877
33AntioxidantsPhase 4, Phase 2, Phase 12928
34AlbuterolPhase 4, Phase 2408
35Tocolytic AgentsPhase 4, Phase 2708
36
Salmeterol xinafoatePhase 4, Phase 235094749-08-356801
Synonyms:
(+-)-4-Hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol 1-hydroxy-2-naphthoate (salt)
(+/-) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate
1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-, 1-hydroxy-2-naphthalenecarboxylate (salt)
1-hydroxynaphthalene-2-carboxylic acid
2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
89365-50-4 (Parent)
94749-08-3
AC1L1LPS
Arial
Asmerole
Beglan
Betamican
Bio-0096
C25H37NO4.C11H8O3
CHEMBL1082607
CID56801
D00687
Dilamax
EU-0101100
GR 33343 G
GR 33343X xinafoate
 
GR-33343 G
Inaspir
LS-94516
MLS001332577
MLS001332578
MolPort-003-850-218
NCGC00094372-01
NCGC00094372-02
NCGC00094372-03
NCGC00094372-04
S5068_SIGMA
SMR000875207
Salmetedur
Salmeterol 1-hydroxy-2-naphthoate
Salmeterol xinafoate (JAN/USAN)
Salmeterol xinafoate [USAN]
Serevent (TN)
Serevent Inhaler and Disks
Serevent diskus
UNII-6EW8Q962A5
Ultrabeta
salmeterol xinafoate
37Adrenergic AgentsPhase 4, Phase 25140
38Neurotransmitter AgentsPhase 4, Phase 3, Phase 217734
39AntacidsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 11767
40Anti-Ulcer AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 11767
41Endothelium-Dependent Relaxing FactorsPhase 4272
42Fluticasone Propionate, Salmeterol Xinafoate Drug CombinationPhase 4, Phase 2201
43
DexlansoprazolePhase 4, Phase 2, Phase 1207138530-94-6, 103577-45-39578005
Synonyms:
138530-94-6
CHEMBL1201863
CID9578005
D08903
Dexlansoprazole (INN/USAN)
KS-1075
 
Kapidex
MolPort-002-885-834
T 168390
TAK 390
UNII-UYE4T5I70X
ZINC00599734
dexlansoprazole
44Methylprednisolone HemisuccinatePhase 4, Phase 31153
45Gastrointestinal AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 18109
46Methylprednisolone acetatePhase 4, Phase 31153
47Antineoplastic Agents, HormonalPhase 4, Phase 2, Phase 35407
48AntiemeticsPhase 4, Phase 23888
49
Proton pump inhibitorsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 11080
Synonyms:
 
PPIs
50Immunoglobulin EPhase 435

Interventional clinical trials:

(show top 50)    (show all 252)
idNameStatusNCT IDPhase
1Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic BronchitisUnknown statusNCT01121016Phase 4
2Effect of Xolair on Airway HyperresponsivenessUnknown statusNCT00208234Phase 4
3Dietetic Versus Topical Steroids for Pediatric Eosinophilic EsophagitisUnknown statusNCT01846962Phase 4
4Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonistsCompletedNCT00670930Phase 4
5Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis SymptomsCompletedNCT00460538Phase 4
6The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic PneumoniaCompletedNCT00632554Phase 4
7Regulatory Lymphocytes in Patients Treated With Specific ImmunotherapyCompletedNCT01475188Phase 4
8Small Particle Steroids in Refractory AsthmaCompletedNCT01171365Phase 4
9Steroid Treatment for Hypereosinophilic SyndromeRecruitingNCT01524536Phase 4
10Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis PatientsRecruitingNCT02605213Phase 4
11Oral Cromolyn Sodium for the Treatment of Eosinophilic EsophagitisRecruitingNCT02371941Phase 4
12Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMAActive, not recruitingNCT02546349Phase 4
13Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma PatientsActive, not recruitingNCT02654145Phase 4
14The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump InhibitorsTerminatedNCT01404832Phase 4
15Mepolizumab Treatment for Rhinovirus-induced Asthma ExacerbationsUnknown statusNCT01520051Phase 3
16A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic DisordersCompletedNCT00266578Phase 3
17Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma ControlCompletedNCT02281318Phase 3
18Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe AsthmaCompletedNCT01508936Phase 3
19A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic AsthmaCompletedNCT01287039Phase 3
20A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic AsthmaCompletedNCT01285323Phase 3
21A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic AsthmaCompletedNCT01270464Phase 3
22Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseCompletedNCT01576367Phase 3
23Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseCompletedNCT01302860Phase 3
24Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension PhaseCompletedNCT00991146Phase 3
25Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseCompletedNCT00685373Phase 3
26Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells SyndromeCompletedNCT00465985Phase 3
27Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 3
28Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic EsophagitisCompletedNCT00635089Phase 3
29Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 YearsCompletedNCT00538434Phase 2, Phase 3
30Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsCompletedNCT00799461Phase 3
31The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic EsophagitisCompletedNCT00728481Phase 2, Phase 3
32Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00006363Phase 3
33Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.RecruitingNCT02563067Phase 3
34Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.RecruitingNCT02555683Phase 3
35Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma PatientsRecruitingNCT02555371Phase 3
36Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)RecruitingNCT00244686Phase 3
37SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet StudyRecruitingNCT02778867Phase 2, Phase 3
38Eosinophilic Esophagitis (EoE) Intervention Trial-Randomized 1 Food Elimination vs. 4 Food Elimination Diet Followed by Swallowed GlucocorticoidsRecruitingNCT02610816Phase 2, Phase 3
39An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)RecruitingNCT02736409Phase 3
40A Placebo- Controlled Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is AchievedRecruitingNCT02605837Phase 3
41Budesonide Effervescent Tablet vs. Placebo in Active Eosinophilic EsophagitisRecruitingNCT02434029Phase 3
42Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY StudyActive, not recruitingNCT02594332Phase 3
43Treatment of Asymptomatic Toxocariasis With Albendazole in ChildrenActive, not recruitingNCT00755560Phase 3
44Eosinophilic Esophagitis Treatment: Montelukast vs FluticasoneActive, not recruitingNCT01702701Phase 3
45Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell TransplantActive, not recruitingNCT01305200Phase 3
46Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic SyndromesActive, not recruitingNCT00369317Phase 3
47Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic AsthmaEnrolling by invitationNCT02559791Phase 2, Phase 3
48Trial of Ketotifen in Children and AdolescentsNot yet recruitingNCT02484248Phase 3
49Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)Not yet recruitingNCT02836496Phase 3
50Safety and Efficacy of Three Doses of Oral Fluticasone Propionate in Adults With Eosinophilic EsophagitisNot yet recruitingNCT02873468Phase 2, Phase 3

Search NIH Clinical Center for Eosinophilia


Cochrane evidence based reviews: eosinophilia

Genetic Tests for Eosinophilia

About this section

Genetic tests related to Eosinophilia:

id Genetic test Affiliating Genes
1 Eosinophilia26

Anatomical Context for Eosinophilia

About this section

MalaCards organs/tissues related to Eosinophilia:

35
Myeloid, Lung, Bone, T cells, Bone marrow, Skin, Testes

Animal Models for Eosinophilia or affiliated genes

About this section

MGI Mouse Phenotypes related to Eosinophilia:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053819.2ETV6, FGFR1, IL13, IL2, IL4, IL5
2MP:00053887.4CCL11, CCL24, CCR3, CSF2, IL13, IL2
3MP:00053976.9CCL11, CCL24, CCL5, CCR3, CSF2, EPX
4MP:00053876.8CCL11, CCL24, CCL5, CCR3, CSF2, EPX

Publications for Eosinophilia

About this section

Articles related to Eosinophilia:

(show top 50)    (show all 1842)
idTitleAuthorsYear
1
Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis. (27081423)
2016
2
Three unusual histopathological presentations of angiolymphoid hyperplasia with eosinophilia. (28035701)
2016
3
Eosinophilia induced by clozapine: a report of two cases and review of the literature. (25811003)
2015
4
Rash, diarrhea, and eosinophilia. (26551473)
2015
5
Traumatic ulcerative granuloma with stromal eosinophilia - Mystery of pathogenesis revisited. (26538890)
2015
6
Host lung immunity is severely compromised during tropical pulmonary eosinophilia: role of lung eosinophils and macrophages. (26489428)
2015
7
Case report of eosinophilia induced by quetiapine. (27199530)
2015
8
Acute lymphoblastic leukemia with eosinophilia lacking peripheral blood leukemic cell: a rare entity. (25332543)
2014
9
Gene-Gene Interaction Between CCR3 and Eotaxin Genes: The Relationship With Blood Eosinophilia in Asthma. (24404394)
2014
10
Changes in blood eosinophilia during omalizumab therapy as a predictor of asthma exacerbation. (25395927)
2014
11
Eosinophilia in mast cell disease. (24745679)
2014
12
Increased FDG Uptake of the Bone Marrow Mimicking Malignancy in a Patient of Eosinophilia Secondary to Sparganum mansoni Infection. (23877523)
2013
13
Prolonged Evolution of Drug Reaction With Eosinophilia and Systemic Symptoms: Clinical, Virologic, and Biological Features. (24369386)
2013
14
Natural history of severe eosinophilia with uncertain aetiology and proposals on a practical approach to its management. (22151137)
2012
15
Cytomorphological spectrum of hydatidosis with eosinophilia, clinically mimicking a malignancy: An uncommon presentation. (22438617)
2012
16
Drug reaction with eosinophilia and systemic symptoms associated with H1N1 vaccination. (23253004)
2012
17
Peripheral eosinophilia camouflaging anaplastic large cell lymphoma. (18805872)
2011
18
Cerebrospinal fluid eosinophilia associated with intraventricular shunts. (21492998)
2011
19
AHR activation by tryptophan--pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome? (19941898)
2010
20
Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics. (19432972)
2009
21
The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia. (16373672)
2006
22
Death receptor-6 regulates the development of pulmonary eosinophilia and airway inflammation in a mouse model of asthma. (16730379)
2006
23
Angiolymphoid hyperplasia with eosinophilia masquerading as Kimura disease. (15888362)
2005
24
Simple pulmonary eosinophilia evaluated by means of FDG PET: the findings of 14 cases. (16374077)
2005
25
Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus. (12738113)
2003
26
Differential susceptibility of C57BL/6 and DBA/2 mice to ovalbumin-induced pulmonary eosinophilia regulated by Th1/Th2-type cytokines. (10569702)
1999
27
Pulmonary eosinophilia associated with montelukast. (10335014)
1999
28
Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. (9034156)
1997
29
The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4. (8818342)
1996
30
Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. (8579979)
1995
31
Pharmacogenetic characteristics of the eosinophilia-myalgia syndrome. (7955801)
1994
32
Unusual widespread type of angiolymphoid hyperplasia with eosinophilia mimicking prurigo nodularis. (8277047)
1993
33
Production of polyclonal antibodies against 1,1'-ethyliden bis[L-tryptophan] (EBT), a potential contaminant causing eosinophilia-myalgia syndrome (EMS). (8475503)
1993
34
Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia. (1540871)
1992
35
Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis. (1918387)
1991
36
Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. (1929872)
1991
37
Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease. (2273104)
1990
38
The eosinophilia-myalgia syndrome. (2339858)
1990
39
Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. (2114933)
1990
40
Prognostic significance of eosinophilia in acute myelomonocytic leukemia in relation to induction treatment. (2323632)
1990
41
Airway hyperreactivity in tropical pulmonary eosinophilia. (3359833)
1988
42
Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. (3668010)
1987
43
Multiple complications of propylthiouracil treatment: granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization. (6221046)
1982
44
Clinical studies in pulmonary eosinophilia. II--Relation of blood eosinophilia and pulmonary manifestations in clinic patients and urban population. (721166)
1978
45
Adrenaline and tropical pulmonary eosinophilia. (1248889)
1976
46
Drug-induced lung disease: pulmonary eosinophilia and sulphonamides. (1236549)
1975
47
Leukocyte adhesion phenomenon in pulmonary eosinophilia (tropical eosinophilia). (4683591)
1973
48
Studies on eosinophilia in parasitic diseases and pellagra. (13755660)
1960
49
The significance of conjunctival eosinophilia in the diagnosis of allergic conjunctivitis. (14896900)
1951
50
Pulmonary eosinophilia (tropical eosinophilia). (18152220)
1949

Variations for Eosinophilia

About this section

Expression for genes affiliated with Eosinophilia

About this section
Search GEO for disease gene expression data for Eosinophilia.

Pathways for genes affiliated with Eosinophilia

About this section

Pathways related to Eosinophilia according to GeneCards Suite gene sharing:

(show all 35)
idSuper pathwaysScoreTop Affiliating Genes
110.0PDGFRA, PDGFRB
29.8FGFR1, PDGFRA, PDGFRB
39.8FGFR1, PDGFRA, PDGFRB
49.8FGFR1, PDGFRA, PDGFRB
5
Show member pathways
9.8FGFR1, PDGFRA, PDGFRB
69.8IL13, IL4, IL5
79.5IL2, IL4, IL5
89.4CSF2, IL3, IL4, IL5
99.4CCL11, CCL26, IL4, IL5
109.2IL13, IL2, IL4, IL5
119.2IL13, IL2, IL4, IL5
129.2CSF2, IL2, PDGFRA, PDGFRB
13
Show member pathways
9.1CSF2, IL2, IL3, IL5
14
Show member pathways
9.1CSF2, IL13, IL3, IL4, IL5
159.0CCL11, IL13, IL2, IL4, IL5
169.0FGFR1, IL2, IL3, PDGFRA, PDGFRB
178.9CSF2, IL13, IL2, IL4, IL5
188.9CSF2, IL13, IL2, IL4, IL5
19
Show member pathways
8.9IL13, IL2, IL3, IL4, IL5
20
Show member pathways
8.8FGFR1, IL13, IL2, IL5, PDGFRA, PDGFRB
21
Show member pathways
8.8CSF2, IL2, IL3, IL4, IL5
228.7FGFR1, IL2, IL3, IL4, PDGFRA, PDGFRB
23
Show member pathways
8.7FGFR1, IL2, IL3, IL4, PDGFRA, PDGFRB
24
Show member pathways
8.4CSF2, FGFR1, IL2, IL3, IL5, PDGFRA
258.4CCR3, CSF2, IL2, IL3, IL4, IL5
26
Show member pathways
8.4CCL11, CCL24, CCL26, CCL5, CCR3
27
Show member pathways
8.4CCL11, CCL24, CCL26, CCL5, CCR3
28
Show member pathways
8.2CCL11, EPX, IL13, IL2, IL3, IL4
29
Show member pathways
7.0CCL11, CCL24, CCL26, CCL5, FGFR1, IL13
306.9CCL11, CCL24, CCL26, CCL5, CSF2, IL13
31
Show member pathways
6.6CCL11, CCL24, CCL26, CCL5, FGFR1, IL13
32
Show member pathways
5.8CCL11, CCL24, CCL26, CCL5, CCR3, CSF2
33
Show member pathways
5.8CCL11, CCL24, CCL26, CCL5, CCR3, CSF2
34
Show member pathways
5.8CCL11, CCL24, CCL26, CCL5, CCR3, CSF2
35
Show member pathways
5.8CCL11, CCL24, CCL26, CCL5, CCR3, CSF2

GO Terms for genes affiliated with Eosinophilia

About this section

Cellular components related to Eosinophilia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055767.5CCL11, CCL5, CSF2, FGFR1, IL13, IL2
2extracellular spaceGO:00056156.7CCL11, CCL24, CCL26, CCL5, CSF2, IL13

Biological processes related to Eosinophilia according to GeneCards Suite gene sharing:

(show all 48)
idNameGO IDScoreTop Affiliating Genes
1metanephric glomerular capillary formationGO:007227710.7PDGFRA, PDGFRB
2positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathwayGO:003809110.7PDGFRA, PDGFRB
3negative regulation of complement-dependent cytotoxicityGO:190366010.7IL13, IL4
4regulation of proton transportGO:001015510.7IL13, IL4
5positive regulation of mast cell degranulationGO:004330610.7IL13, IL4
6cardiac myofibril assemblyGO:005500310.6PDGFRA, PDGFRB
7positive regulation of immunoglobulin productionGO:000263910.6IL13, IL4
8positive regulation of phospholipase C activityGO:001086310.6FGFR1, PDGFRA, PDGFRB
9response to fluid shear stressGO:003440510.6CSF2, PDGFRB
10positive regulation of podosome assemblyGO:007180310.6CSF2, IL5
11microglial cell activationGO:000177410.5IL13, IL4
12dendritic cell differentiationGO:009702810.5CSF2, IL4
13positive regulation of immunoglobulin secretionGO:005102410.5IL2, IL5
14phosphatidylinositol phosphorylationGO:004685410.5FGFR1, PDGFRA, PDGFRB
15regulation of phosphatidylinositol 3-kinase signalingGO:001406610.5FGFR1, PDGFRA, PDGFRB
16chronic inflammatory responseGO:000254410.4CCL11, CCL5
17retina vasculature development in camera-type eyeGO:006129810.4PDGFRA, PDGFRB
18positive regulation of isotype switching to IgG isotypesGO:004830410.4IL2, IL4
19positive regulation of T cell differentiationGO:004558210.3IL2, IL4
20positive regulation of smooth muscle cell proliferationGO:004866110.2CCL5, IL13, PDGFRB
21positive regulation of peptidyl-tyrosine phosphorylationGO:005073110.1IL3, IL4, IL5
22positive regulation of phosphatidylinositol 3-kinase signalingGO:001406810.0CCL5, FGFR1, PDGFRA, PDGFRB
23eosinophil chemotaxisGO:00482459.9CCL11, CCL24, CCL5
24positive regulation of DNA replicationGO:00457409.9CSF2, IL3, PDGFRA
25positive regulation of B cell proliferationGO:00308909.9IL13, IL2, IL4, IL5
26positive regulation of T cell proliferationGO:00421029.7CCL5, IL2, IL4
27positive regulation of tyrosine phosphorylation of Stat5 proteinGO:00425239.6CSF2, IL2, IL3, IL4
28positive regulation of actin filament polymerizationGO:00308389.6CCL11, CCL24, CCL26
29peptidyl-tyrosine phosphorylationGO:00181089.5CSF2, FGFR1, IL3, IL5, PDGFRA, PDGFRB
30monocyte chemotaxisGO:00025489.4CCL11, CCL24, CCL26, CCL5
31cellular response to interleukin-1GO:00713479.4CCL11, CCL24, CCL26, CCL5
32lymphocyte chemotaxisGO:00482479.3CCL11, CCL24, CCL26, CCL5
33cellular response to interferon-gammaGO:00713469.3CCL11, CCL24, CCL26, CCL5
34positive regulation of endothelial cell proliferationGO:00019389.3CCL11, CCL24, CCL26, CCR3
35neutrophil chemotaxisGO:00305939.3CCL11, CCL24, CCL26, CCL5
36cellular response to tumor necrosis factorGO:00713569.3CCL11, CCL24, CCL26, CCL5
37positive regulation of angiogenesisGO:00457669.3CCL11, CCL24, CCL5, CCR3
38positive regulation of inflammatory responseGO:00507298.9CCL11, CCL24, CCL26, CCL5, IL2
39chemokine-mediated signaling pathwayGO:00700988.8CCL11, CCL24, CCL26, CCL5, CCR3
40chemotaxisGO:00069358.5CCL11, CCL24, CCL26, CCL5, CCR3, IL4
41inflammatory responseGO:00069548.3CCL11, CCL24, CCL26, CCL5, CCR3, IL13
42cell-cell signalingGO:00072678.3CCL24, CCL26, CCL5, IL13, IL2, IL3
43positive regulation of cell migrationGO:00303358.3CCL11, CCL24, CCL26, CCL5, PDGFRA, PDGFRB
44MAPK cascadeGO:00001658.2CCL5, CSF2, FGFR1, IL2, IL3, IL5
45positive regulation of cell proliferationGO:00082848.2CSF2, FGFR1, IL2, IL3, IL4, IL5
46positive regulation of ERK1 and ERK2 cascadeGO:00703748.1CCL11, CCL24, CCL26, CCL5, PDGFRA, PDGFRB
47immune responseGO:00069557.7CCL24, CCL26, CSF2, IL13, IL2, IL3
48positive regulation of GTPase activityGO:00435476.9CCL11, CCL24, CCL26, CCL5, CSF2, FGFR1

Molecular functions related to Eosinophilia according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1vascular endothelial growth factor bindingGO:003808510.6PDGFRA, PDGFRB
2platelet-derived growth factor receptor bindingGO:000516110.6PDGFRA, PDGFRB
3platelet-derived growth factor bindingGO:004840710.5PDGFRA, PDGFRB
4phosphatidylinositol-4,5-bisphosphate 3-kinase activityGO:004693410.3FGFR1, PDGFRA, PDGFRB
5CCR chemokine receptor bindingGO:00480209.6CCL11, CCL24, CCL26
6protein tyrosine kinase activityGO:00047139.2CSF2, FGFR1, IL3, IL5, PDGFRB
7chemokine activityGO:00080099.0CCL11, CCL24, CCL26, CCL5
8growth factor activityGO:00080838.5CSF2, IL2, IL3, IL4, IL5
9Ras guanyl-nucleotide exchange factor activityGO:00050888.4CSF2, FGFR1, IL2, IL3, IL5, PDGFRA
10cytokine activityGO:00051258.1CCL24, CSF2, IL13, IL2, IL3, IL4

Sources for Eosinophilia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet